Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy
The Journal of Infectious Diseases · 14.06.2024 · 229 (6) · 1786-1790
DOI: 10.1093/infdis/jiae009 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 16.01.2024. Verfasst von Francesca Scrimieri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Proviruses, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH Clinical Center, National Institute of Allergy and Infectious Diseases, NIH HHS.
Abstract (Originalsprache)
A subset of antiretroviral therapy-treated persons with human immunodeficiency virus (HIV), referred to as immunological nonresponders (INRs), fails to normalize CD4+ T-cell numbers. In a case-control study involving 26 INRs (CD4 < 250 cells/µL) and 25 immunological responders (IRs; CD4 ≥ 250 cells/µL), we evaluated the potential contribution of transcriptionally competent defective HIV-1 proviruses to poor CD4+ T-cell recovery. Compared to the responders, the INRs had higher levels of cell-associated HIV RNA (P = .034) and higher percentages of HLA-DR+ CD4+ T cells (P < .001). While not encoding replication-competent viruses, the RNA transcripts frequently encoded HIV-1 Gag-p17 and Nef proteins. These transcripts and/or resulting proteins may activate pathway(s) leading to the immunological nonresponse phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
ORCID-Profile: Weizhong Chang, Hiromi Imamichi
Förderung
- NIH Clinical Center
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- NHLBI NIH HHS
- CCR NIH HHS
- NCI NIH HHS
- Division of Intramural Research
- National Institutes of Health
Zitieren
APA
Scrimieri, F., Bastian, E., Smith, M., Rehm, C. A., Morse, C., Kuruppu, J., McLaughlin, M., Chang, W., Sereti, I., Kovacs, J. A., Lane, H. C., & Imamichi, H. (2024). Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy. The Journal of Infectious Diseases, 229(6), 1786-1790. https://doi.org/10.1093/infdis/jiae009
Vancouver
Scrimieri F, Bastian E, Smith M, Rehm CA, Morse C, Kuruppu J, et al. Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy. The Journal of Infectious Diseases. 2024;229(6):1786-1790. doi:10.1093/infdis/jiae009
BibTeX
@article{Scrimieri2024,
author = {Scrimieri, Francesca and Bastian, Estella and Smith, Mindy and Rehm, Catherine A and Morse, Caryn and Kuruppu, Janaki and McLaughlin, Mary and Chang, Weizhong and Sereti, Irini and Kovacs, Joseph A and Lane, H Clifford and Imamichi, Hiromi},
title = {Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {229},
number = {6},
pages = {1786--1790},
doi = {10.1093/infdis/jiae009}
}
EUVIMED